Filed: 10/20/2023ACC: 0000950123-23-008898
📋 What this filing means
INTERWEST VENTURE MANAGEMENT CO filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $20.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$20.64M
Total AUM (reported)
6.46M
Total Shares
Allocation by class
COM$16.14M78.2%
CLASS A COM$4.49M21.8%
Portfolio Concentration
Top 3$19.38M93.9%
4–10$1.26M6.1%
Top 3 weight
93.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 6.46M
Sole
Full voting authority
6.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
PMV PHARMACEUTICALS INC
SOLEShares1.61M
TypeSH
Market value$9.92M
48.05%
Sole
1.61M
Shared
0.00
None
0.00
THE REALREAL
SOLEShares2.35M
TypeSH
Market value$4.97M
24.07%
Sole
2.35M
Shared
0.00
None
0.00
SERA PROGNOSTICS
SOLEShares2.42M
TypeSH
Market value$4.49M
21.78%
Sole
2.42M
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares16.35K
TypeSH
Market value$1.23M
5.96%
Sole
16.35K
Shared
0.00
None
0.00
DARE BIOSCIENCE INC
SOLEShares62.06K
TypeSH
Market value$28.7K
0.14%
Sole
62.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PMV PHARMACEUTICALS INCSOLE | COM | 1.61M | SH | $9.92M 48.05% | 1.61M | 0.00 | 0.00 |
THE REALREALSOLE | COM | 2.35M | SH | $4.97M 24.07% | 2.35M | 0.00 | 0.00 |
SERA PROGNOSTICSSOLE | CLASS A COM | 2.42M | SH | $4.49M 21.78% | 2.42M | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 16.35K | SH | $1.23M 5.96% | 16.35K | 0.00 | 0.00 |
DARE BIOSCIENCE INCSOLE | COM | 62.06K | SH | $28.7K 0.14% | 62.06K | 0.00 | 0.00 |